Generics 9

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Ertugliflozin manufacturers

9 products found

Filters

9 products found

ertugliflozin

Tablets 5 mg, 15 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #261
A pharmaceutical manufacturer based in the EU that has been selling its products in Europe for 20+ years. Main therapeutic areas include diabetes, CNL, dermatology, and oncology. Main dosage forms include solid and liquid oral, sterile dosage forms, and ointments. The company possesses 10+ manufacturing facilities that are cGMP-compliant.

Manufacturer usually replies in 2 days

ertugliflozin

Tablets, film coated 5 mg, 15 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
Turkey
GMP approvals
EU GMP, PICS
Manufacturer #13510
It was established in the 2010s. It creates and sells biotech products developed with natural product extracts, helping to improve your heart health, immune system, or mood. It offers the pharmaceutical and nutraceutical industry a natural, science-based therapeutic alternative that can be safely used either in combination with existing medications as add-on ingredients for improved efficacy or presented as a single standing remedy; with patented products, proven benefits, and claims for our natural ingredients in the areas of for example mood improvement, anxiety and stress reduction, eye-health, cardiovascular health advancement and enhancement of the body´s immune system against cold and flu.

Manufacturer usually replies in 11 days

ertugliflozin

Tablets 5 mg, 15 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #34252

Established in 2004, this vertically integrated pharmaceutical manufacturer is committed to delivering high-quality, affordable medicines globally. As a CTD dossier owner and manufacturer, it holds GMP certifications from the US FDA, EU, and WHO, ensuring compliance with stringent international quality standards. The company's state-of-the-art R&D center is capable of handling oral solids, liquids, and parenteral formulations. Its products have received marketing authorizations from regulatory authorities such as the US FDA, Health Canada, CDSCO-India, and New Zealand. With over 20 ANDA/ANDs under approval, the manufacturer operates advanced production lines adhering to rigorous GMP guidelines. Its diverse portfolio includes therapeutics in areas like antivirals, neurology, women's health, cardiology, and imaging contrast agents.

Want to see all 9 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible